Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: A prospective study

Amy L. Gross, Craig J. Newschaffer, Judith Hoffman-Bolton, Nader Rifai, Kala Visvanathan

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Obesity is a known risk factor for postmenopausal breast cancer; it has been postulated that adipocytokines may mediate this association. We explored the relationship between three markers altered by obesity: leptin, adiponectin, and soluble tumor necrosis factor receptor 2 (sTNF-R2), an inflammatory marker, with breast cancer risk in postmenopausal women. A nested case-control study of postmenopausal women was conducted within CLUE II, a prospective population-based cohort. Baseline plasma levels of leptin, adiponectin, and sTNF-R2 were assayed in 272 female breast cancer cases and 272 controls matched on age, date, and hour of blood draw. Conditional logistic regression was used to estimate matched odds ratios (OR) and 95% confidence intervals (CI). sTNF-R2 and leptin were independently positively associated with breast cancer risk in adjusted models. The OR for breast cancer comparing the highest to lowest tertile was 2.44 (95% CI: 1.30-4.58) for sTNFR2 and 1.98 (95% CI: 1.20-3.29) for leptin. While higher levels of adiponectin were protective (OR for the lowest tertile = 1.63; 95% CI: 1.02-2.60), there was no dose response. A 20% reduction in the breast cancer risk associated with overweight/obesity was observed when sTNF-R2 alone was included in multivariable models. Including both sTNF-R2 and adiponectin in the models resulted in a 29% reduction in the OR. Adipocytokines and sTNF-R2 are important factors in the etiology of postmenopausal breast cancer due to adiposity. This study informs our understanding of the relationship between obesity, inflammation, and postmenopausal breast cancer and identifies potential biomarkers.

Original languageEnglish (US)
Pages (from-to)1319-1324
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume22
Issue number7
DOIs
StatePublished - Jul 1 2013

Fingerprint

Adipokines
Receptors, Tumor Necrosis Factor, Type II
Prospective Studies
Breast Neoplasms
Inflammation
Adiponectin
Leptin
Obesity
Odds Ratio
Confidence Intervals
Adiposity
Case-Control Studies
Biomarkers
Logistic Models

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology

Cite this

Gross, Amy L. ; Newschaffer, Craig J. ; Hoffman-Bolton, Judith ; Rifai, Nader ; Visvanathan, Kala. / Adipocytokines, inflammation, and breast cancer risk in postmenopausal women : A prospective study. In: Cancer Epidemiology Biomarkers and Prevention. 2013 ; Vol. 22, No. 7. pp. 1319-1324.
@article{843ec1454e144e8d9946eb451cd2b377,
title = "Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: A prospective study",
abstract = "Obesity is a known risk factor for postmenopausal breast cancer; it has been postulated that adipocytokines may mediate this association. We explored the relationship between three markers altered by obesity: leptin, adiponectin, and soluble tumor necrosis factor receptor 2 (sTNF-R2), an inflammatory marker, with breast cancer risk in postmenopausal women. A nested case-control study of postmenopausal women was conducted within CLUE II, a prospective population-based cohort. Baseline plasma levels of leptin, adiponectin, and sTNF-R2 were assayed in 272 female breast cancer cases and 272 controls matched on age, date, and hour of blood draw. Conditional logistic regression was used to estimate matched odds ratios (OR) and 95{\%} confidence intervals (CI). sTNF-R2 and leptin were independently positively associated with breast cancer risk in adjusted models. The OR for breast cancer comparing the highest to lowest tertile was 2.44 (95{\%} CI: 1.30-4.58) for sTNFR2 and 1.98 (95{\%} CI: 1.20-3.29) for leptin. While higher levels of adiponectin were protective (OR for the lowest tertile = 1.63; 95{\%} CI: 1.02-2.60), there was no dose response. A 20{\%} reduction in the breast cancer risk associated with overweight/obesity was observed when sTNF-R2 alone was included in multivariable models. Including both sTNF-R2 and adiponectin in the models resulted in a 29{\%} reduction in the OR. Adipocytokines and sTNF-R2 are important factors in the etiology of postmenopausal breast cancer due to adiposity. This study informs our understanding of the relationship between obesity, inflammation, and postmenopausal breast cancer and identifies potential biomarkers.",
author = "Gross, {Amy L.} and Newschaffer, {Craig J.} and Judith Hoffman-Bolton and Nader Rifai and Kala Visvanathan",
year = "2013",
month = "7",
day = "1",
doi = "10.1158/1055-9965.EPI-12-1444",
language = "English (US)",
volume = "22",
pages = "1319--1324",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "7",

}

Adipocytokines, inflammation, and breast cancer risk in postmenopausal women : A prospective study. / Gross, Amy L.; Newschaffer, Craig J.; Hoffman-Bolton, Judith; Rifai, Nader; Visvanathan, Kala.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 22, No. 7, 01.07.2013, p. 1319-1324.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adipocytokines, inflammation, and breast cancer risk in postmenopausal women

T2 - A prospective study

AU - Gross, Amy L.

AU - Newschaffer, Craig J.

AU - Hoffman-Bolton, Judith

AU - Rifai, Nader

AU - Visvanathan, Kala

PY - 2013/7/1

Y1 - 2013/7/1

N2 - Obesity is a known risk factor for postmenopausal breast cancer; it has been postulated that adipocytokines may mediate this association. We explored the relationship between three markers altered by obesity: leptin, adiponectin, and soluble tumor necrosis factor receptor 2 (sTNF-R2), an inflammatory marker, with breast cancer risk in postmenopausal women. A nested case-control study of postmenopausal women was conducted within CLUE II, a prospective population-based cohort. Baseline plasma levels of leptin, adiponectin, and sTNF-R2 were assayed in 272 female breast cancer cases and 272 controls matched on age, date, and hour of blood draw. Conditional logistic regression was used to estimate matched odds ratios (OR) and 95% confidence intervals (CI). sTNF-R2 and leptin were independently positively associated with breast cancer risk in adjusted models. The OR for breast cancer comparing the highest to lowest tertile was 2.44 (95% CI: 1.30-4.58) for sTNFR2 and 1.98 (95% CI: 1.20-3.29) for leptin. While higher levels of adiponectin were protective (OR for the lowest tertile = 1.63; 95% CI: 1.02-2.60), there was no dose response. A 20% reduction in the breast cancer risk associated with overweight/obesity was observed when sTNF-R2 alone was included in multivariable models. Including both sTNF-R2 and adiponectin in the models resulted in a 29% reduction in the OR. Adipocytokines and sTNF-R2 are important factors in the etiology of postmenopausal breast cancer due to adiposity. This study informs our understanding of the relationship between obesity, inflammation, and postmenopausal breast cancer and identifies potential biomarkers.

AB - Obesity is a known risk factor for postmenopausal breast cancer; it has been postulated that adipocytokines may mediate this association. We explored the relationship between three markers altered by obesity: leptin, adiponectin, and soluble tumor necrosis factor receptor 2 (sTNF-R2), an inflammatory marker, with breast cancer risk in postmenopausal women. A nested case-control study of postmenopausal women was conducted within CLUE II, a prospective population-based cohort. Baseline plasma levels of leptin, adiponectin, and sTNF-R2 were assayed in 272 female breast cancer cases and 272 controls matched on age, date, and hour of blood draw. Conditional logistic regression was used to estimate matched odds ratios (OR) and 95% confidence intervals (CI). sTNF-R2 and leptin were independently positively associated with breast cancer risk in adjusted models. The OR for breast cancer comparing the highest to lowest tertile was 2.44 (95% CI: 1.30-4.58) for sTNFR2 and 1.98 (95% CI: 1.20-3.29) for leptin. While higher levels of adiponectin were protective (OR for the lowest tertile = 1.63; 95% CI: 1.02-2.60), there was no dose response. A 20% reduction in the breast cancer risk associated with overweight/obesity was observed when sTNF-R2 alone was included in multivariable models. Including both sTNF-R2 and adiponectin in the models resulted in a 29% reduction in the OR. Adipocytokines and sTNF-R2 are important factors in the etiology of postmenopausal breast cancer due to adiposity. This study informs our understanding of the relationship between obesity, inflammation, and postmenopausal breast cancer and identifies potential biomarkers.

UR - http://www.scopus.com/inward/record.url?scp=84880011766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880011766&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-12-1444

DO - 10.1158/1055-9965.EPI-12-1444

M3 - Article

C2 - 23651666

AN - SCOPUS:84880011766

VL - 22

SP - 1319

EP - 1324

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 7

ER -